Yahoo
Copenhagen - Free Realtime Quote DKK

ChemoMetec A/S (CHEMM.CO)

619.00 -2.00 (-0.32%)
As of 2:32:56 PM GMT+1. Market Open.
Chart Range Bar
Loading chart for CHEMM.CO
  • Previous Close 621.00
  • Open 623.00
  • Bid 617.00 x --
  • Ask 619.00 x --
  • Day's Range 614.50 - 626.50
  • 52 Week Range 235.20 - 803.00
  • Volume 12,033
  • Avg. Volume 67,055
  • Market Cap (intraday) 10.624B
  • Beta (5Y Monthly) 1.37
  • PE Ratio (TTM) 53.36
  • EPS (TTM) 11.60
  • Earnings Date Sep 10, 2026
  • Forward Dividend & Yield 7.00 (0.00%)
  • Ex-Dividend Date Oct 10, 2025
  • 1y Target Est 641.67

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter NC-203, a high-precision cell counter designed to deliver complex cell samples; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops XcytoMatic 30 cell counter and Xcyto 5. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.

chemometec.com

174

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .

YTD Return

CHEMM.CO
9.96%
OMX Copenhagen 25 Index (^OMXC25)
8.35%

1-Year Return

CHEMM.CO
21.84%
OMX Copenhagen 25 Index (^OMXC25)
16.99%

3-Year Return

CHEMM.CO
140.62%
OMX Copenhagen 25 Index (^OMXC25)
23.36%

5-Year Return

CHEMM.CO
33.74%
OMX Copenhagen 25 Index (^OMXC25)
0.26%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 119.76M
Earnings --
Profit Margin 0.00%

Q1

FY26

Q2

FY26

Q3

FY26

Q4

FY26

0
50M
100M
0.0%

Analyst Insights

View More

Analyst Price Targets

550.00 Low
641.67 Average
619.00 Current
735.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 10/29/2026
  • Market Cap

    10.66B

  • Enterprise Value

    10.37B

  • Trailing P/E

    53.53

  • Forward P/E

    --

  • PEG Ratio (current)

    2.98

  • Price/Sales (ttm)

    21.15

  • Price/Book (mrq)

    14.81

  • Enterprise Value/Revenue

    20.29

  • Enterprise Value/EBITDA

    36.35

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    39.49%

  • Return on Assets (ttm)

    18.45%

  • Return on Equity (ttm)

    28.56%

  • Revenue (ttm)

    511.06M

  • Net Income Avi to Common (ttm)

    201.84M

  • Diluted EPS (ttm)

    11.60

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    293.56M

  • Total Debt/Equity (mrq)

    0.63%

  • Levered Free Cash Flow (ttm)

    57.36M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: